Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Ventech in connection with their investment in Mindler
Mandate

Vinge has advised Ventech in connection with their investment in Mindler

April 14, 2020

Vinge has advised Ventech, a leading Seed & Series A-focused European venture capital firm, in connection with their investment in Mindler, Sweden’s largest digital service for mental health.

The series A round, which raised EUR 8 million, was led by Ventech and co-led by Schibsted Growth. The funds raised will be used to accelerate Mindler’s European expansion and to reinforce the startup’s organizational growth and platform development.
 
Vinge’s team consisted of Johan Larsson, Maria Dahlin Kolvik, Karl-Hugo Engdahl and Elsie Nassar.

 

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025